Investor Relations

Board of Directors

David Richards MBE


Chairman, President, CEO and Co-founder


Length of tenure

Appointed 11 May 2012 (Chairman from 6 October 2016)

Skills and experience

Since co-founding the Company in Silicon Valley in 2005, David has led WANdisco on a course for rapid international expansion, opening offices in the UK, Japan and China. David spearheaded WANdisco to a hugely successful listing on the London Stock Exchange (WAND:LSE) and, shortly after, the acquisition of AltoStor, which accelerated the development of WANdisco’s first products for the Big Data market.

A passionate advocate of entrepreneurship, David has established and successfully exited several highly successful Silicon Valley technology companies. David was the founder and CEO of Librados, an application integration software provider, and led the company’s acquisition by NASDAQ-listed NetManage, Inc. in 2005. David is a frequent commentator on a range of business and technology issues, appearing regularly on Bloomberg and CNBC. David holds a BSc in Computer Science from the University of Huddersfield.

After Paul Walker, the former Chairman, stepped down from the Board in October 2016, David took the role of Chairman. In 2017 David was awarded an Honorary Doctorate by Sheffield Hallam University in recognition of him being a champion of British technology and a passionate advocate of entrepreneurship.

David and his wife Jane founded the David & Jane Richards Family Foundation with the purpose to educate, empower and improve the lives of children through hands-on programmes and targeted assistance. They aim to encourage children to fulfil their potential and make a positive impact on the world around them. The first programmes commenced in 2018 in some state schools in the UK, where they will use new methods to teach computing skills and install beehives as part of a wider teaching curriculum.

In the 2022 Queen’s New Year Honours List, David was awarded an MBE for his services to the Information Technology Sector and to Young People, particularly during COVID-19.

External appointments

With over 20 years of executive experience in the software industry, David sits on a number of advisory and executive boards of Silicon Valley start-up ventures.


Dr. Yeturu Aahlad


Chief Scientist, Inventor & Co-Founder


Length of tenure

Appointed 23 February 2017

Skills and experience

Dr Aahlad is a recognised worldwide authority on distributed computing. He is named in 73 WANdisco patents, including US and international patents, continuations and divisionals. It was Dr Aahlad’s vision and years of persistence that led to the invention of technology that many thought was impossible – that of Active-Active replication (WANdisco’s patented DConE technology). Prior to WANdisco, Dr Aahlad served as the distributed systems architect for iPlanet (Sun/Netscape Alliance) Application Server. At Netscape, Dr Aahlad joined the elite team in charge of creating a new server platform based on the CORBA distributed object framework.

Prior to Sun/Netscape Dr Aahlad worked on incorporating the CORBA security service into Fujitsu’s Object Request Broker. Dr Aahlad designed and implemented the CORBA event services while working on Sun’s first CORBA initiative. Earlier in his career, Dr Aahlad worked on a distributed programming language at IBM’s Palo Alto Scientific Center.

Dr Aahlad has a PhD in Distributed Computing from the University of Texas, Austin, and a BSc in Electrical Engineering from IIT Madras.

External appointments

None.


Peter Lees


Independent Non-Executive Director.


Length of tenure

Appointed 10 August 2022

Skills and experience

Mr Lees has built a successful 35-year career in the UK financial markets, having served in senior leadership roles across multiple financial institutions, with a particular focus on Equity Capital Markets and the provision of investment and strategic advice to public and private companies.

Mr Lees has built, grown and led a number of UK, European and Global Equity teams during his career, including most recently serving as a Managing Director at Stifel, where he was part of the leadership team in the Technology and Life Science sectors. Prior to that, Mr Lees served as Head of UK and European teams at F&C, responsible for managing over £15 billion of assets under management. Earlier in his career, Mr Lees rose to become Head of the UK Equity Team at Morgan Grenfell (latterly, Deutsche Bank), helping to drive the organisation towards its ultimate position as one of the top three Asset Management companies in London.

External appointments

None.


Erik Miller


Chief Financial Officer


Length of tenure

Appointed 5 December 2016

Skills and experience

Erik was the Chief Financial Officer of Envivio, Inc., a NASDAQ-listed provider of video transcoding software, from February 2010 to January 2016, following its acquisition by Ericsson AB.

From January 2008 to July 2009, Erik served as Chief Financial Officer at SigNav Pty. Ltd., a component supplier to the wireless industry, where he was responsible for finance and administration functions.

From March 2006 to January 2008, he served as Chief Financial Officer at Tangler Pty. Ltd., a social networking company, where he was responsible for finance and administrative functions. Erik received a BS degree in Business Administration from the University of California, Berkeley.

External appointments

None.


Grant Dollens


Non-executive Director


Length of tenure

Appointed 9 October 2016

Skills and experience

Prior to founding Global Frontier Investments, LLC, Grant was an Investment Analyst and member of the investment committee for Ayer Capital, a long/short equity healthcare fund, where he was focused on medical devices, diagnostics, healthcare services, biotechnology and pharmaceutical investments.

Prior to Ayer, Grant was an Associate in the healthcare group at BA Venture Partners (now Scale Ventures), where he sourced, evaluated and invested in private medical device, biotechnology, specialty pharmaceutical and healthcare service companies. Before BA Venture Partners, Grant was an Investment Banking Analyst in corporate finance at Deutsche Bank Alex. Brown focused on the technology sector.

Grant received his MBA from the Kellogg School of Management at Northwestern University, with majors in Analytical Finance, Management and Strategy, and Accounting. He received his BSc in Biomedical Engineering from Duke University.

External appointments

Grant founded Global Frontier Investments, LLC, a long-term oriented global equities fund, in 2010 and serves as its Portfolio Manager. Grant is also a member of the board of ColdQuanta, Inc.


Karl Monaghan


Non-executive Director


Length of tenure

Appointed 5 December 2016

Skills and experience

Karl brings a wealth of capital markets and board experience. Prior to founding Ashling Capital, Karl has worked in corporate finance for Robert W. Baird, Credit Lyonnais Securities, Bank of Ireland, Johnson Fry and BDO Stoy Hayward.

Additionally, he trained as a Chartered Accountant with KPMG in Dublin and holds a Bachelor of Commerce degree from University College Dublin.

External appointments

Karl is currently Managing Partner at Ashling Capital LLP, which he founded in December 2002, to provide consultancy services to both quoted and private companies.

Karl is also currently a Non-executive Director of AIM company CareTech Holdings plc.


Ensuring the long-term success of the Group

Board effectiveness

Board composition and responsibilities

The Board comprises three Executive Directors (including the Chairman) and three Non-executive Directors, two of which are independent (Peter Lees and Karl Monaghan).

The Board is responsible for the long-term success of the Group. It has established a strategy and business model which promote long-term value for shareholders as outlined in the Strategic report on pages 6 to 35. It sets the Group’s values, standards and strategic aims and oversees implementation within a framework of prudent and effective controls, ensuring only acceptable risks are taken.

It provides leadership and direction and is also responsible for corporate governance and the overall financial performance of the Group. In addition, it promotes a corporate culture that is based on ethical values and behaviours; these corporate values guide the objectives and strategy of the Company.

The corporate values are reflected in everything that the Company does, beginning with the selection criteria used in the employee recruitment process and continuing throughout all elements of the Company’s business.

The Board ensures that ethical behaviours are expected, and followed, by approving a set of internal policies on matters such as whistleblowing.

The Board also ensures that appropriate systems and controls are in place to ensure compliance with those policies as part of its efforts to promote a healthy corporate culture, which is for the benefit of all stakeholders.

Meeting Attendance
David Richards
Bob Corey
Erik Miller
Dr Yeturu Aahlad
Grant Dollens
Karl Monaghan
Attended
Did not attend
Not required to attend

Board and Committee meetings

The table above shows the number of Board meetings held during the year, and the attendance of each Director. See our Committee reports for Audit, Remuneration and Nomination Committee meetings.

Board Committees

To assist the Board in carrying out its functions and to ensure that there is independent oversight of internal controls and risk management, the Board delegates certain responsibilities to its three principal Committees as shown in the governance framework diagram below.

Governance framework

Board

Executive Team

Chaired by the Chief Executive Officer, it comprises the three Executive Directors and senior management representation from product, marketing, engineering, business development, finance, legal, HR, sales and support. It assists the Executive Directors in implementing the business plan and policies and managing the operational and financial performance of the Company.

Nomination Committee
Audit Committee
Renumeration Committee

Audit Committee

Committee composition

Karl Monaghan is the Chairman of the Committee and the other member of the Committee is Grant Dollens. The Board considers Bob Corey to have relevant and recent financial experience, given his biography set out on page 38.

Committee responsibilities

The Audit Committee (“the Committee”) is established by and is responsible to the Board. It has written terms of reference, which are available for review at www.wandisco.com. Its main responsibilities are:

  • to monitor and be satisfied that the Group’s financial statements are fair, balanced and understandable before submission to the Board for approval, ensuring their compliance with the appropriate accounting standards, the law and the AIM Rules;
  • to monitor and review the effectiveness of the Group’s system of internal control;
  • to make recommendations to the Board in relation to the appointment of the external auditor and its remuneration, following appointment by the shareholders in general meeting, and to review and be satisfied with the auditor’s independence, objectivity and effectiveness on an ongoing basis; and
  • to implement the policy relating to any non‑audit services performed by the external auditor.

The Committee is authorised by the Board to seek and obtain any information it requires from any officer or employee of the Group and to obtain external legal or other independent professional advice as is deemed necessary by it.

Committee meetings

There were two meetings of the Committee during the year scheduled to coincide with the review of the scope of the external audit and observations arising from its work in relation to internal control, and to review the financial statements. The external auditor attended one of these meetings. Since the end of the financial year, the Committee has met twice (in February 2022 and June 2022) to consider, amongst other matters, this Annual Report, with the external auditor being present at these meetings. The Committee also met with the external auditor, without the Executive Directors being present, once during the year.
Committee meeting attendance
Bob Corey
Grant Dollens
Karl Monaghan
Attended
Did not attend
Not required to attend
committee 2020

The Renumeration Committee

The Board, as required by the QCA Code, supports the principle of transparency and has prepared this report in order to provide information to shareholders on executive remuneration arrangements.

Committee composition

The Remuneration Committee is chaired by Peter Lees and the other member of the Committee is Grant Dollens.

Committee responsibilities

The Remuneration Committee’s primary purposes are to assist the Board in determining the Company’s remuneration policies, review the performance of the Executive Directors and make recommendations to the Board on matters relating to their remuneration and terms of service, the granting of share options, and other equity incentives.

Committee meetings

The Remuneration Committee met two times in the year, with the other Board members in attendance as appropriate. Remuneration Committee report The content of this report is unaudited unless stated.

Committee meeting attendance
Karl Monaghan
Bob Corey
Grant Dollens
Attended
Did not attend
Not required to attend
committee 2020

Nomination Committee

The Nomination Committee assists the Board in determining Board appointments and succession planning for Directors.

Committee composition

The Nomination Committee is chaired by David Richards and the other members of the Committee are Peter Lees, Grant Dollens, Karl Monaghan and Erik Miller.

Committee responsibilities

The Nomination Committee has responsibility for: reviewing the structure, size and composition of the Board and recommending to the Board any changes required; succession planning; and identifying and nominating for approval Board candidates to fill vacancies as and when they arise. The Committee is also responsible for reviewing the results of any Board performance evaluation process and making recommendations to the Board concerning the Board’s Committees and the re-election of Directors at the AGM. The membership of the Nomination Committee comprises the three Non‑executive Directors, David Richards and Erik Miller. The Nomination Committee is required to meet not less than once a year and at such other times as required. It has written terms of reference, which are available for review at www.wandisco.com.

Committee meetings

The Nomination Committee met once during the year, with the Chief Executive Officer and Chief Financial Officer in attendance. The Board has considered diversity in broader terms than just gender and believes it is also important to have the correct balance of skills, experience, independence and knowledge on the Board. All Board appointments will be made on merit and with the aim of achieving a correct balance. The Group has formal policies in place to promote equality of opportunity across the whole organisation and training is provided to assist this. Currently, there are no women on the Board. As opportunities arise, the Board will seek to increase the presence of women on the Board consistent with the above policy and the terms of reference of the Nomination Committee.
Meeting Attendance
David Richards
Bob Corey
Erik Miller
Grant Dollens
Karl Monaghan
Attended
Did not attend
Not required to attend
committee 2020

DISCLAIMER – IMPORTANT

DISCLAIMER – IMPORTANT

ELECTRONIC VERSIONS OF THE INFORMATION AND MATERIALS YOU ARE SEEKING TO ACCESS, TO WHICH THIS GATEPOST GIVES ACCESS, ARE BEING MADE AVAILABLE ON THIS WEBSITE BY WANDISCO PLC (THE “COMPANY”) IN GOOD FAITH AND ARE FOR INFORMATION PURPOSES ONLY.

THESE MATERIALS ARE NOT DIRECTED AT OR ACCESSIBLE BY PERSONS LOCATED IN OR RESIDENT IN (OR ORGANISED OR INCORPORATED UNDER THE LAWS OF) THE UNITED STATES, THE COMMONWEALTH OF AUSTRALIA, ITS TERRITORIES AND POSSESSIONS, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR SWITZERLAND, OR ANY OTHER JURISDICTION WHERE THE EXTENSION OF AVAILABILITY OF THE MATERIALS TO WHICH YOU ARE SEEKING ACCESS WOULD BREACH ANY APPLICABLE LAW OR REGULATION.

The information and materials you are seeking to access do not constitute or form a part of any offer to sell, or a solicitation of an offer to purchase or subscribe for, any securities of the Company in the United States (including any state, possession or territory) or any other jurisdiction where it is unlawful to do so. Any securities issued in connection with an offering have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “US Securities Act”), or under any applicable securities laws of any state, province, possession, territory, county or jurisdiction of the United States, Australia, Canada or Japan. Such securities may not be offered or sold in the United States or to, or for the account or benefit of, US persons (as defined in Regulation S under the US Securities Act) unless registered under the US Securities Act or pursuant to an exemption from, or in a transaction not subject to, such registration. Further, unless an exemption under relevant securities laws is applicable, any such securities may not be offered, sold, resold, taken up, exercised, renounced, transferred, delivered or distributed, directly or indirectly, in or into the United States, Australia, Canada, Japan, or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration of such securities in, the relevant jurisdiction.  There will be no public offer of securities of the Company in the United States.

The information and materials you are seeking access to are only addressed to and directed at persons in member states of the European Economic Area (“EEA”) who are “qualified investors” within the meaning of Article 2(E) of the prospectus regulation 2017/1129 ("Prospectus Regulation") (and any amendments thereto) (“Qualified Investors”). In addition, in the United Kingdom, the materials are being distributed only to, and are directed at Qualified Investors who (a) fall within the definition of "investment professionals" within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (b) are high net worth entities, and other persons as described in Article 49(2)(a) to (d) of the Order or, otherwise to persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as “Relevant Persons”). Any investment or investment activity to which these materials relates are available only to Relevant Persons in the United Kingdom and Qualified Investors in any member state of the EEA other than the United Kingdom, and will be engaged in only with such persons.

If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage. These materials must not be, released or otherwise forwarded, distributed or sent to any US persons or in or into the United States, Australia, Canada, Japan, or any jurisdiction in which such offers or sales are unlawful. Persons receiving such documents (including custodians, nominees and trustees) must not distribute or send them to any US persons or in, or into the United States, Australia, Canada, Japan, or any other jurisdiction in which such offers or sales are unlawful.

Confirmation of understanding and acceptance of disclaimer

By clicking “I CONFIRM” below, you:

(i)        confirm that you have read and understood the disclaimer set out above, that you understand that it may affect your rights, that you agree to be bound by its terms and that you confirm that you are permitted to proceed to this part of the website;

(ii)        certify that you are not a US person (as defined in Regulation S of the US Securities Act) or a resident of or located in the United States or a person acting on behalf of the foregoing and agree that you will not retransmit, send or otherwise transfer any of the information contained on this website to any US person or person in or resident in the United States; and

(iii) warrant that you are not a resident of or located in Australia, Canada or Japan or any other jurisdiction where accessing these materials is unlawful, and you agree that you will not retransmit, send or otherwise transfer any of the information contained on this website to any person in Australia, Canada, Japan or any other jurisdiction where to do so would breach applicable local law or regulation.

PLEASE NOTE that it is your responsibility to satisfy yourself as to the full observance of any relevant laws and regulatory requirements.  If you are in any doubt, you should not continue to seek access to this area of the website.

Wandisco Plc does not accept any responsibility for any contravention of applicable securities laws and regulations by individuals as a result of false information provided by such individuals.

3497099 v2

Cookies and Privacy

At WANdisco, we respect your concerns about privacy and value the relationship that we have with you.

Like many companies, we use technology on our website to collect information that helps us enhance your experience and our products and services. The cookies that we use at WANdisco allow our website to work and help us to understand what information and advertising is most useful to visitors.

Please take a moment to familiarise yourself with our cookie practices and let us know if you have any questions by getting in touch through any of the methods listed on our "Contact Us" page.

We have tried to keep this Notice as simple as possible, but if you’re not familiar with terms, such as cookies, IP addresses, and browsers, then read about these key terms first.